Evidence map›Paper›PMID 37504267›Full record

ArticleCurrent issues in molecular biology2023

Microbiomic and Metabolomic Analyses Unveil the Protective Effect of Saffron in a Mouse Colitis Model.

Gulshan Singh, Hassan Brim, Yeneneh Haileselassie, Sudhir Varma, Aida Habtezion, Mudasir Rashid, Sidhartha R Sinha, Hassan Ashktorab

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current issues in molecular biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Gulshan SinghDivision of Gastroenterology and Hepatology, School of Medicine, Stanford University, Palo Alto, CA 94305, USA.
Hassan BrimDepartment of Pathology, Howard University College of Medicine, Washington, DC 20059, USA.
Yeneneh HaileselassieDivision of Gastroenterology and Hepatology, School of Medicine, Stanford University, Palo Alto, CA 94305, USA.
Sudhir VarmaHithru Analytics LLC, Silver Spring, MD 20877, USA.ORCID 0000-0002-4096-4782
Aida HabtezionDivision of Gastroenterology and Hepatology, School of Medicine, Stanford University, Palo Alto, CA 94305, USA.
Mudasir RashidDepartment of Pathology and Cancer Center, College of Medicine, Howard University College of Medicine, Washington, DC 20059, USA.ORCID 0000-0001-9342-6243
Sidhartha R SinhaDivision of Gastroenterology and Hepatology, School of Medicine, Stanford University, Palo Alto, CA 94305, USA.ORCID 0000-0001-5104-6410
Hassan AshktorabDepartment of Pathology and Cancer Center, College of Medicine, Howard University College of Medicine, Washington, DC 20059, USA.ORCID 0000-0002-4048-4666
Stanford University · USHoward University · US

Funding

Inactivation of MSH3 in Colorectal Cancer and RaceR01CA258519 · UNIVERSITY OF CALIFORNIA, SAN DIEGO · 2025 to 2025
$572k
NCI NIH HHS R01 CA258519NIMHD NIH HHS G12 MD007597NIMHD NIH HHS G12MD007597
6 · The paper itself

Abstract

Despite the existence of effective drugs used to treat inflammatory bowel disease (IBD), many patients fail to respond or lose response over time. Further, many drugs can carry serious adverse effects, including increased risk of infections and malignancies. Saffron (

Indexed as

colitisinflammationmetabolitesmicrobiomesaffron

Identifiers

PMID37504267
PMCPMC10378474
OpenAlexW4382983660

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.